Delivery Order SPE2DB22D3016-SPE2DB25FBDF6
Award Date 7/28/25
Potential Completion Date 8/18/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $23,272.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (40 gram/400 ml vial), with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract that will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a single transaction within AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $41,178.10 on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $34,908 on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's demonstrated capability to compete in the...
- The Defense Logistics Agency awarded a $1,220.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 10 Gram/100 ML vials totaling 100 ML. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor serving military and veteran...
- The Defense Logistics Agency awarded a $7,080.84 delivery order contract to AmerisourceBergen Drug Corp for GAMUNEX-C (Immune Globulin Intravenous [Human]), a specialized pharmaceutical product supplied in 20 gram/200 milliliter vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine replenishment order under...
- The Defense Logistics Agency awarded a delivery order valued at $9,522.72 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials. This is a firm fixed price contract with an ultimate completion date of August 18, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $9,157.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 10 gram/100 mL vials with a completion date of August 14, 2025. This competitively awarded, non-set-aside contract represents a single delivery order sourced through AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-competitive delivery order, which must be completed by August 15, 2025, represents a firm fixed-price transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $46,544 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999 valuation through December 2026. The product will...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Gamunex-C (immune globulin intravenous human 10% solution), a specialized immunoglobulin therapy product in 20 gram/200 milliliter vials. This firm fixed-price delivery order, valued at $35,404.20, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with a completion date of...